As filed with the Securities and Exchange Commission on June 2, 2021.
Registration Nos. 333-251898
333-210073
333-180171
333-163806
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT NO. 333-251898
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT NO. 333-210073
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT NO. 333-180171
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT NO. 333-163806
UNDER
THE SECURITIES ACT OF 1933
CANTEL MEDICAL LLC
f/k/a Cantel Medical Corp.
(Exact Name of Registrant as specified in its charter)
| | |
Delaware | | 22-1760285 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
150 Clove Road, Little Fallas, New Jersey 07424
(Address of Principal Executive Offices) (Zip Code)
2020 EQUITY INCENTIVE PLAN
2016 EQUITY INCENTIVE PLAN
CANTEL MEDICAL CORP. 2006 EQUITY INCENTIVE PLAN
(Full Title of the Plan)
Ronald Snyder
Secretary
5960 Heisley Road
Mertor, Ohio 44060
(Name and address of agent for service)
(440) 354-2600
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☒ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☐ | | Smaller reporting company | | ☐ |
| | | |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐